Malignant News and Research

RSS

INESC Porto, FEUP develop software to automatically analyse and validate mammograms

INESC Porto and FEUP developed software to automatically analyse and validate mammograms. The software, Semantic PACS, can be incorporated into hospital IT systems and it categorises each new mammography using automatic descriptive methods and search methods that compare the semantic contents of the images stored.

12 May 2011

Reprogrammed herpes virus can improve early cancer diagnosis

Scientists have used a genetically re-engineered herpes virus that selectively hunts down and infects cancerous tumors and then delivers genetic material that prompts cancers to secrete a biomarker and reveal their presence.

12 May 2011

Protein critical to formation of new blood vessels could lead to therapies to starve cancerous tumors

UT Southwestern Medical Center researchers have discovered a protein that guides blood vessel development and eventually might lead to a treatment to keep cancer cells from spreading.

11 May 2011

UCLA researchers amp up power of killer CD8 T-cells to fight melanoma

Researchers with UCLA's Jonsson Comprehensive Cancer Center have discovered a way to amp up the power of killer T-cells, called CD8 cells, making them more functional for longer periods of time and boosting their ability to multiply and expand within the body to fight melanoma, a new study has found.

11 May 2011

Micromet first quarter total revenues decrease to $5.5 million

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the first quarter ended March 31, 2011.

10 May 2011

Dermatologists to provide free melanoma screenings at Loyola Center for Health on May 20

During a free health fair at work that offered screenings for skin cancer, Joan Rojek decided on a whim to have a dermatologist examine some odd-looking blemishes on her arm.

10 May 2011

Boston Scientific launches Expect Endoscopic Ultrasound Aspiration Needle

Boston Scientific Corporation today announced the U.S. and international launch of its Expect™ Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples for diagnosing and staging malignancies in organs adjacent to the gastrointestinal tract. The Expect Needle received FDA clearance and CE Mark approval earlier this year and is being marketed in the U.S., Europe and other international markets.

9 May 2011

Period of observation can avoid unnecessary head CT scan use in children

Overall, roughly half of U.S. children taken to hospital emergency departments for a head injury receive a head CT scan, often to ease worried parents' concerns. Yet true traumatic brain injury is uncommon.

9 May 2011

Brain cancer research needs $50 billion to find cure

According to one of Australia's leading neurosurgeons a massive increase in funding is needed to find a cure for brain cancer. Brain cancer kills one Australian every eight hours. About 1,400 cases of malignant brain cancer are diagnosed in Australia every year and about 1,100 people die from the disease.

8 May 2011

WWP2 protein appears to play a key role in tumor survival

A protein known as WWP2 appears to play a key role in tumor survival, a research team headed by a scientist at The University of Texas MD Anderson Cancer Center reports in an advance online publication of Nature Cell Biology.

4 May 2011

Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma

A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.

2 May 2011

No proven advantages of PET for diagnostic accuracy of head and neck tumours: Research

The benefit and harm of positron emission tomography in patients with head and neck tumours, applied alone or in combination with computed tomography, cannot currently be reliably assessed.

30 Apr 2011

MarginProbe System meets its primary endpoints: Dune Medical Devices

Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.

30 Apr 2011

Three hundred neurosurgeons to participate in Central Park softball tournament

With summer just around the corner, that means the Annual Neurosurgery Charity Softball Tournament will take place in Central Park for the eighth consecutive year.

30 Apr 2011

IOF, ANZBMS to hold osteoporosis and bone meeting in Asia-Pacific region

IOF and the ANZBMS, together with the Japanese Bone and Mineral Research Society, invite researchers and clinicians with an interest in osteoporosis and bone research to attend the year's most important bone meeting in the Asia-Pacific region.

29 Apr 2011

Unanticipated structure at chromosome ends could be key ingredient in biological 'elixir of life'

In stark contrast to normal cells, which only divide a finite number of times before they enter into a permanent state of growth arrest or simply die, cancer cells never cease to proliferate. Now, scientists at the Salk Institute for Biological Studies have uncovered an important clue to one of the mechanisms underlying cancer cell immortality.

22 Apr 2011

Study finds ACE inhibitors linked to increased risk of recurrence in women who have had breast cancer

ACE inhibitors, commonly used to control high blood pressure and heart failure in women, may be associated with an increased risk of recurrence in women who have had breast cancer, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.

21 Apr 2011

Ludwig Institute demonstrates ability of DAVANAT to enhance efficacy of T-lymphocytes to kill tumor cells

Pro-Pharmaceuticals, Inc. today announced that the Brussels Branch of the Ludwig Institute for Cancer Research demonstrated the ability of GM-CT-01 (DAVANAT®) to enhance the ability of tumor-specific T-lymphocytes to kill tumor cells.

20 Apr 2011

Researchers discover new way to force cancer cells to self-destruct

Researchers at The Wistar Institute have found a new way to force cancer cells to self-destruct. Low doses of one anti-cancer drug currently in development, called Gamitrinib, sensitize tumor cells to a second drug, called TRAIL, also currently in clinical development as part of an anticancer regimen.

20 Apr 2011

Minimizing neurological side effects in high-grade glioma patients may improve survival

Minimizing neurological side effects in patients with high-grade glioma from chemoradiation may result in improved patient survival, a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests. These findings were reported in the April issue of the British Journal of Cancer.

20 Apr 2011

Malignant News and Research

INESC Porto, FEUP develop software to automatically analyse and validate mammograms

Reprogrammed herpes virus can improve early cancer diagnosis

Protein critical to formation of new blood vessels could lead to therapies to starve cancerous tumors

UCLA researchers amp up power of killer CD8 T-cells to fight melanoma

Micromet first quarter total revenues decrease to $5.5 million

Dermatologists to provide free melanoma screenings at Loyola Center for Health on May 20

Boston Scientific launches Expect Endoscopic Ultrasound Aspiration Needle

Period of observation can avoid unnecessary head CT scan use in children

Brain cancer research needs $50 billion to find cure

WWP2 protein appears to play a key role in tumor survival

Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma

No proven advantages of PET for diagnostic accuracy of head and neck tumours: Research

MarginProbe System meets its primary endpoints: Dune Medical Devices

Three hundred neurosurgeons to participate in Central Park softball tournament

IOF, ANZBMS to hold osteoporosis and bone meeting in Asia-Pacific region

Unanticipated structure at chromosome ends could be key ingredient in biological 'elixir of life'

Study finds ACE inhibitors linked to increased risk of recurrence in women who have had breast cancer

Ludwig Institute demonstrates ability of DAVANAT to enhance efficacy of T-lymphocytes to kill tumor cells

Researchers discover new way to force cancer cells to self-destruct

Minimizing neurological side effects in high-grade glioma patients may improve survival

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News